Related Experiment Video
Updated: Jun 3, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets
Jan A Burger1, Mariela Sivina, Farhad Ravandi
1Department of Leukemia, The University of Texas M D Anderson Cancer Center, Houston, TX 77230-1402, USA. jaburger@mdanderson.org
Insights
Hairy cell leukemia cells interact with their microenvironment, crucial for survival and proliferation. Targeting these interactions, including chemokine receptors and B cell receptor signaling, offers new therapeutic strategies for HCL.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Hairy cell leukemia (HCL) is characterized by neoplastic B cell accumulation in the spleen and bone marrow.
- HCL cells interact with the surrounding microenvironment, involving accessory cells, matrix proteins, and cytokines.
- Surface receptors on HCL cells mediate critical cross-talk with their microenvironment, influencing cell behavior.
Purpose of the Study:
- To summarize key cellular and molecular interactions between HCL cells and their microenvironment.
- To outline future therapeutic strategies targeting the HCL microenvironment.
Main Methods:
- Review of literature on HCL cell-microenvironment interactions.
- Focus on surface receptors like chemokine receptors, adhesion molecules, B cell antigen receptor (BCR), and CD40.
- Discussion of potential therapeutic targets including CXCR4 and kinase inhibitors.
Main Results:
- Identified critical roles for surface receptors (e.g., CXCR4, BCR signaling components) in HCL cell homing, retention, survival, and expansion.
- Highlighted the significance of microenvironmental interactions for HCL pathogenesis.
- Noted that similar pathways are being targeted in other mature B-cell malignancies.
Conclusions:
- The microenvironment plays a pivotal role in hairy cell leukemia.
- Targeting specific pathways, such as CXCR4 and B cell receptor signaling (Syk, Btk, PI3K), presents promising therapeutic avenues for HCL.
Abstract:
Hairy cell leukemia (HCL) cells accumulate and proliferate in the spleen and the bone marrow. In these tissue compartments, HCL cells interact with accessory cells, matrix proteins, and various cyctokines, collectively referred to as the 'microenvironment.' Surface receptors expressed on HCL cells and respective stromal ligands are critical for this cross-talk between HCL cells and the microenvironment. Chemokine receptors, adhesion molecules (integrins, CD44), the B cell antigen receptor (BCR), and CD40, expressed on the HCL cells, are likely to be critical for homing, retention, survival, and expansion of the neoplastic B cells. Some of these pathways are now targeted in first clinical trials in other mature B-cell malignancies. We summarize key aspects of the cellular and molecular interactions between HCL cells and their microenvironment. Also, we outline future prospects for therapeutic targeting of the microenvironment in HCL, focusing on CXCR4 and kinase inhibitors (Syk, Btk, phosphatidylinositol 3-kinase [PI3K]) that target B cell receptor signaling.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Regulation of Hematopoietic Stem Cells
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Differentiation of Common Myeloid Progenitor Cells

